Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma. [electronic resource]
Producer: 20190403Description: 268-278 p. digitalISSN:- 1745-7254
- Cell Line, Tumor
- Drug Resistance, Neoplasm -- drug effects
- Humans
- Imidazoles -- pharmacology
- MAP Kinase Signaling System -- drug effects
- Melanoma -- drug therapy
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Mutation
- Oximes -- pharmacology
- Phosphorylation -- drug effects
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Pyridones -- pharmacology
- Pyrimidinones -- pharmacology
- Ribosomal Protein S6 -- metabolism
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.